Astellas Pharma Inc (OTC Pink - Current Information:ALPMF:US)

15.47
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
13.00
Today|||52-Week Range
18.11
-9.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Revenue and IncomeNet Revenues11.4B12.1B11.7B11.8B
 
 
 
 
 
Cost of Goods Sold2.6B2.7B2.4B2.4B
 
 
 
 
 
Depreciation And Amortization576.2M589.1M585.2M572.2M
 
 
 
 
 
 
Operating ExpensesGross Income8.3B8.8B8.8B8.8B
 
 
 
 
 
General Expenses6.0B6.3B6.3B6.3B
 
 
 
 
 
Research And Development1.9B1.9B2.0B1.9B
 
 
 
 
 
Total Operating Expenses9.2B9.6B9.3B9.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.3B2.6B2.4B2.5B
 
 
 
 
 
Extraordinary Credit----72.4M0.00
 
 
Extraordinary Charge-189.3M-252.7M-470.5M-396.9M
 
 
 
 
 
Pre-Tax Equity Earnings---17.2M-21.8M-14.7M
 
 
 
 
Interest Expense On Debt10.5M12.3M11.8M11.7M
 
 
 
 
 
Equity In Earnings-10.4M------
 
 
Other Expenses118.2M321.7M-62.5M118.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.2B2.6B2.0B2.2B
 
 
 
 
 
Income Taxes-567.0M-582.4M-482.1M-240.8M
 
 
 
 
 
Net Income1.6B2.0B1.5B2.0B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.2B2.1B2.0B1.9B
 
 
 
 
 
Shares To Calculate EPS Diluted2.2B2.1B2.0B1.9B
 
 
 
 
 
 
Earnings Per ShareEPS$0.75$0.96$0.73$1.04
 
 
 
 
 
EPS Diluted$0.75$0.96$0.73$1.04